ASHLEY CLEMONS: Open Payments
NPI 1811746043 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 43 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,084
Food & beverage: $918Education: $166
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 14 | $403 |
| Janssen Biotech, Inc. | 8 | $202 |
| Regeneron Healthcare Solutions, Inc. | 6 | $201 |
| ABBVIE INC. | 4 | $81 |
| UCB, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Incyte Corporation | 1 | $25 |
| ConvaTec Inc. | 1 | $25 |
| GENZYME CORPORATION | 1 | $19 |
Products named: NEMLUVIO, DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, OPZELURA, INNOVAMATRIX AC, RINVOQ.
Industry payments across KY — which companies pay providers there.
